Journal of Oncology and Cancer Research

About the Journal

The Journal of Oncology and Cancer Research is a peer-reviewed, international, open-access journal dedicated to accelerating progress in the prevention, diagnosis, treatment, and management of cancer across all disciplines and geographies. As oncology continues to evolve with breakthroughs in molecular biology, immunotherapy, personalized medicine, and digital health, Journal of Oncology and Cancer Research offers a dynamic platform for researchers, clinicians, oncologists, and healthcare professionals to publish cutting-edge findings that directly impact cancer care and patient outcomes. The journal welcomes original research, systematic reviews, meta-analyses, clinical trials, case reports, and translational studies that advance our understanding of tumor biology and improve cancer care practices worldwide. 
Journal of Oncology and Cancer Research covers a broad spectrum of topics, including medical, surgical, and radiation oncology; hematologic malignancies; cancer genetics and epigenetics; cancer immunotherapy; targeted therapies; precision oncology; early detection and biomarkers; oncologic imaging; supportive and palliative care; survivorship; cancer prevention and screening; and health disparities in oncology. We are particularly interested in high-impact, interdisciplinary studies that integrate basic science, clinical practice, and population health, as well as innovations in AI-based diagnostics, wearable technology, nanomedicine in oncology, and real-world evidence from diverse care settings. 
All submissions undergo a rigorous double-blind peer-review process overseen by an international editorial board to ensure scientific excellence, ethical integrity, and relevance to a global readership. Through our open-access model, every published article is freely accessible to clinicians, researchers, educators, policymakers, and patients alike, empowering informed decisions and inclusive knowledge sharing across the cancer care continuum. Journal of Oncology and Cancer Research also actively promotes research from low- and middle-income countries, acknowledging the urgent need for global equity in oncology research and access to treatment. 
In the face of a growing global cancer burden, the Journal of Oncology and Cancer Research stands as a committed ally in the fight against cancer a space for thought leadership, scientific discovery, and collaboration across borders. Whether you're uncovering molecular mechanisms of metastasis, piloting community-based cancer screening, evaluating novel therapeutics, or advocating for policy change, Journal of Oncology and Cancer Research is your platform to amplify impact, influence care, and save lives. 

Authors are requested to submit manuscripts online at Submit Manuscript or Send as an e-mail attachment to the Editorial Office at editor@confmeets.net

Rapid Publication Service

Confmeets Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.

The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.

Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.

Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.

Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.